| MLEC | Moolec Science SA | 0.01 | -99.86% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -99.65% |
| ENVB | Enveric Biosciences Inc | 0.08 | -98.77% |
| CASI | CASI Pharmaceuticals Inc | 0.12 | -98.14% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -97.77% |
| JAGX | Jaguar Health Inc | 0.30 | -95.28% |
| LITS | Lite Strategy Inc | 0.31 | -95.14% |
| AFMD | Affimed N.V. | 0.53 | -91.81% |
| HRTX | Heron Therapeutics Inc | 0.54 | -91.62% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -91.06% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -90.52% |
| FTRE | Fortrea Holdings Inc | 0.63 | -90.30% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -90.00% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -88.81% |
| CELU | Celularity Inc - Class A | 0.85 | -86.81% |
| SRPT | Sarepta Therapeutics Inc | 0.87 | -86.53% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.97 | -84.95% |
| GOSS | Gossamer Bio Inc | 0.98 | -84.86% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -82.65% |
| XLO | Xilio Therapeutics Inc | 1.14 | -82.37% |
| PTN | Palatin Technologies Inc | 1.22 | -81.04% |
| BOLT | Bolt Biotherapeutics Inc | 1.25 | -80.68% |
| FBIOP | Fortress Biotech Inc | 1.25 | -80.64% |
| HCWB | HCW Biologics Inc | 1.25 | -80.62% |
| CRIS | Curis Inc | 1.30 | -79.75% |
| IMRN | Immuron Ltd | 1.34 | -79.22% |
| CSBR | Champions Oncology Inc | 1.36 | -78.96% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -78.36% |
| RVNC | Revance Therapeutics Inc | 1.48 | -77.03% |
| KPTI | Karyopharm Therapeutics Inc | 1.50 | -76.71% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -75.90% |
| MDXG | Mimedx Group Inc | 1.61 | -75.08% |
| SPRO | Spero Therapeutics Inc | 1.61 | -75.04% |
| VNDA | Vanda Pharmaceuticals Inc | 1.61 | -74.94% |
| CRMD | CorMedix Inc | 1.62 | -74.83% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -73.61% |
| AGEN | Agenus Inc | 1.71 | -73.50% |
| MGNX | Macrogenics Inc | 1.74 | -73.07% |
| GLPG | Galapagos NV | 1.74 | -73.00% |
| SVA | Sinovac Biotech Ltd | 1.83 | -71.59% |
| PBYI | Puma Biotechnology Inc | 1.85 | -71.22% |
| NERV | Minerva Neurosciences Inc | 1.87 | -71.02% |
| FBIO | Fortress Biotech Inc | 1.87 | -70.94% |
| THTX | Theratechnologies Inc | 1.98 | -69.23% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | -67.23% |
| NAGE | Niagen Bioscience Inc | 2.12 | -67.12% |
| XBIO | Xenetic Biosciences Inc | 2.15 | -66.56% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | -65.59% |
| MGX | Metagenomi Inc | 2.23 | -65.48% |
| HRMY | Harmony Biosciences Holdings Inc | 2.25 | -65.14% |
| NVAX | Novavax Inc | 2.32 | -63.97% |
| SPRC | SciSparc Ltd | 2.33 | -63.82% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | -62.20% |
| PLX | Protalix BioTherapeutics Inc | 2.44 | -62.19% |
| HYFT | MindWalk Holdings Corp | 2.48 | -61.55% |
| CDXS | Codexis Inc | 2.48 | -61.54% |
| SAVA | Cassava Sciences Inc. | 2.54 | -60.64% |
| RIGL | Rigel Pharmaceuticals | 2.54 | -60.58% |
| PHAR | Pharming Group N.V. | 2.55 | -60.37% |
| CTXR | Citius Pharmaceuticals Inc | 2.60 | -59.61% |
| VRCA | Verrica Pharmaceuticals Inc | 2.62 | -59.41% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | -58.78% |
| APVO | Aptevo Therapeutics Inc | 2.70 | -58.05% |
| REVB | Revelation Biosciences Inc | 2.88 | -55.28% |
| SABS | SAB Biotherapeutics Inc | 2.96 | -54.09% |
| ARDX | Ardelyx Inc | 2.98 | -53.76% |
| CGEN | Compugen Ltd | 2.99 | -53.55% |
| VERU | Veru Inc | 3.11 | -51.75% |
| ATRA | Atara Biotherapeutics Inc | 3.13 | -51.42% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 3.13 | -51.36% |
| EVGN | Evogene Ltd | 3.17 | -50.80% |
| ICCC | Immucell Corp | 3.24 | -49.68% |
| BGMS | Bio Green Med Solution Inc | 3.28 | -49.16% |
| AAPG | Ascentage Pharma Group International | 3.28 | -49.09% |
| MNKD | Mannkind Corp | 3.32 | -48.44% |
| VALN | Valneva SE | 3.35 | -48.05% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.36 | -47.85% |
| JAZZ | Jazz Pharmaceuticals plc | 3.37 | -47.73% |
| EVAX | Evaxion Biotech A/S | 3.38 | -47.57% |
| PTHS | Channel Therapeutics Corporation | 3.41 | -47.05% |
| BMRN | Biomarin Pharmaceutical Inc | 3.50 | -45.76% |
| BCAB | BioAtla Inc | 3.54 | -45.15% |
| SLDB | Solid Biosciences Inc | 3.65 | -43.45% |
| CUE | Cue Biopharma Inc | 3.66 | -43.28% |
| IPSC | Century Therapeutics Inc | 3.72 | -42.33% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | -41.06% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.81 | -40.95% |
| INVA | Innoviva Inc | 3.81 | -40.82% |
| CLLS | Cellectis | 3.85 | -40.20% |
| LEGN | Legend Biotech Corp | 3.91 | -39.29% |
| ONCO | Onconetix Inc | 3.92 | -39.10% |
| ACAD | Acadia Pharmaceuticals Inc | 3.98 | -38.17% |
| ADMA | Adma Biologics Inc | 4.03 | -37.44% |
| IMCR | Immunocore Holdings plc | 4.27 | -33.70% |
| INCY | Incyte Corp | 4.28 | -33.58% |
| PHAT | Phathom Pharmaceuticals Inc | 4.30 | -33.27% |
| IVVD | Invivyd Inc | 4.31 | -33.16% |
| STRO | Sutro Biopharma Inc | 4.33 | -32.90% |
| GERN | Geron Corp | 4.51 | -29.96% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | -29.10% |
| GMAB | Genmab | 4.58 | -28.99% |
| BCYC | Bicycle Therapeutics Plc | 4.64 | -28.01% |
| TARS | Tarsus Pharmaceuticals Inc | 4.69 | -27.25% |
| RARE | Ultragenyx Pharmaceutical Inc | 4.71 | -26.95% |
| ABUS | Arbutus Biopharma Corp | 4.76 | -26.19% |
| TLX | Telix Pharmaceuticals Ltd | 4.76 | -26.18% |
| APLM | Apollomics Inc - Class A | 4.77 | -26.05% |
| REGN | Regeneron Pharmaceuticals Inc | 4.77 | -25.98% |
| CHRS | Coherus Biosciences Inc | 4.77 | -25.98% |
| TRAW | Traws Pharma Inc | 4.77 | -25.95% |
| QTTB | Q32 Bio Inc | 4.95 | -23.14% |
| ZLAB | Zai Lab Ltd | 4.96 | -22.97% |
| DTIL | Precision Biosciences Inc | 5.04 | -21.80% |
| ACHV | Achieve Life Sciences Inc | 5.09 | -21.03% |
| VYGR | Voyager Therapeutics Inc | 5.23 | -18.85% |
| ELAB | PMGC Holdings Inc | 5.26 | -18.37% |
| PSTV | Plus Therapeutics Inc | 5.42 | -15.91% |
| CAI | Caris Life Sciences Inc - Class A | 5.44 | -15.60% |
| ENTA | Enanta Pharmaceuticals Inc | 5.51 | -14.51% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.61 | -12.96% |
| ONC | BeiGene Ltd | 5.63 | -12.65% |
| RNA | Atrium Therapeutics Inc | 5.70 | -11.56% |
| EXEL | Exelixis Inc | 5.89 | -8.61% |
| HALO | Halozyme Therapeutics Inc | 5.90 | -8.46% |
| ARVN | Arvinas Inc | 5.98 | -7.22% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | -6.66% |
| GYRE | Gyre Therapeutics Inc | 6.04 | -6.29% |
| SCPH | scPharmaceuticals Inc | 6.10 | -5.42% |
| IOVA | Iovance Biotherapeutics Inc | 6.14 | -4.74% |
| ZVRA | Zevra Therapeutics Inc | 6.26 | -2.87% |
| KROS | Keros Therapeutics Inc | 6.58 | +2.09% |
| MRKR | Marker Therapeutics Inc | 6.63 | +2.87% |
| OBIO | Orchestra BioMed Holdings Inc | 6.68 | +3.64% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.89 | +6.90% |
| ANAB | AnaptysBio Inc | 6.90 | +7.06% |
| FDMT | 4D Molecular Therapeutics Inc | 6.92 | +7.37% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | +10.62% |
| TCRX | Tscan Therapeutics Inc | 7.14 | +10.73% |
| RGNX | Regenxbio Inc | 7.23 | +12.18% |
| LENZ | LENZ Therapeutics Inc | 7.45 | +15.59% |
| ASMB | Assembly Biosciences Inc | 7.46 | +15.74% |
| SPRY | ARS Pharmaceuticals Inc | 7.57 | +17.45% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | +17.54% |
| ALGS | Aligos Therapeutics Inc | 7.59 | +17.76% |
| FENC | Fennec Pharmaceuticals Inc | 7.60 | +17.92% |
| PRTA | Prothena Corporation plc | 7.62 | +18.23% |
| NTBL | Notable Labs Inc Ord | 7.65 | +18.69% |
| SEER | Seer Inc - Class A | 7.83 | +21.48% |
| PTCT | PTC Therapeutics Inc | 7.83 | +21.48% |
| VTGN | VistaGen Therapeutics Inc | 7.96 | +23.50% |
| TBPH | Theravance Biopharma Inc | 7.99 | +23.97% |
| CYCN | Cyclerion Therapeutics Inc | 8.06 | +25.05% |
| VCEL | Vericel Corp | 8.06 | +25.05% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | +25.83% |
| IMMP | Immutep Ltd | 8.12 | +25.98% |
| BNTX | BioNTech SE | 8.29 | +28.62% |
| ARQT | Arcutis Biotherapeutics Inc | 8.36 | +29.71% |
| IONS | Ionis Pharmaceuticals Inc | 8.58 | +33.12% |
| ALNY | Alnylam Pharmaceuticals Inc | 8.76 | +35.91% |
| ALEC | Alector Inc | 9.04 | +40.26% |
| GOVX | Geovax Labs Inc | 9.09 | +41.03% |
| TECH | Bio-Techne Corp | 9.17 | +42.28% |
| LPCN | Lipocine Inc | 9.51 | +47.55% |
| NXTC | Nextcure Inc | 9.52 | +47.71% |
| BLRX | Bioline Rx Ltd | 9.56 | +48.33% |
| ACET | Adicet Bio Inc | 9.72 | +50.81% |
| SNGX | Soligenix Inc | 9.78 | +51.74% |
| TVTX | Travere Therapeutics Inc | 9.84 | +52.67% |
| SNDX | Syndax Pharmaceuticals Inc | 9.85 | +52.83% |
| VSTM | Verastem Inc | 9.87 | +53.14% |
| VRTX | Vertex Pharmaceuticals Inc | 9.89 | +53.45% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.04 | +55.77% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | +58.41% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | +61.20% |
| OABI | OmniAb Inc | 10.42 | +61.67% |
| PYXS | Pyxis Oncology Inc | 10.69 | +65.86% |
| MDGL | Madrigal Pharmaceuticals Inc | 10.93 | +69.58% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | +73.00% |
| ARGX | Argen X SE | 11.27 | +74.86% |
| FHTX | Foghorn Therapeutics Inc | 11.34 | +75.94% |
| XNCR | Xencor Inc | 11.41 | +77.03% |
| DYAI | Dyadic International Inc DE | 11.58 | +79.67% |
| PALI | Palisade Bio Inc | 11.78 | +82.77% |
| CCCC | C4 Therapeutics Inc | 11.93 | +85.10% |
| TGTX | TG Therapeutics Inc | 12.00 | +86.18% |
| MRNA | Moderna Inc | 12.18 | +88.98% |
| XBIT | XBiotech Inc | 12.23 | +89.75% |
| CORT | Corcept Therapeutics Inc | 12.63 | +95.96% |
| MDWD | MediWound Ltd | 12.65 | +96.27% |
| ICU | SeaStar Medical Holding Corp | 12.86 | +99.53% |
| MIRM | Mirum Pharmaceuticals Inc | 12.95 | +100.92% |
| SRRK | Scholar Rock Holding Corp | 13.14 | +103.87% |
| RPRX | Royalty Pharma plc - Class A | 13.14 | +103.87% |
| URGN | UroGen Pharma Ltd | 13.37 | +107.44% |
| LXRX | Lexicon Pharmaceuticals Inc | 13.52 | +109.77% |
| ANL | Adlai Nortye Ltd | 13.52 | +109.83% |
| ATHE | Alterity Therapeutics Ltd | 13.60 | +111.01% |
| XCUR | Exicure Inc | 13.61 | +111.16% |
| CRVO | CervoMed Inc | 13.61 | +111.16% |
| SLGL | Sol-Gel Technologies Ltd | 13.67 | +112.09% |
| EDIT | Editas Medicine Inc | 13.68 | +112.25% |
| KURA | Kura Oncology Inc | 13.93 | +116.13% |
| GDTC | CytoMed Therapeutics Ltd | 14.02 | +117.52% |
| COYA | Coya Therapeutics Inc | 14.30 | +121.87% |
| NUVB | Nuvation Bio Inc - Class A | 14.36 | +122.80% |
| MGTX | MeiraGTx Holdings plc | 14.58 | +126.21% |
| XOMA | XOMA Royalty Corp | 14.63 | +126.99% |
| CVAC | CureVac N.V. | 14.83 | +130.09% |
| APLT | Applied Therapeutics Inc | 14.86 | +130.56% |
| RCUS | Arcus Biosciences Inc | 14.93 | +131.64% |
| CRBU | Caribou Biosciences Inc | 15.32 | +137.69% |
| IDYA | Ideaya Biosciences Inc | 15.70 | +143.59% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.28 | +152.59% |
| WVE | Wave Life Sciences Ltd | 16.43 | +154.92% |
| CLGN | CollPlant Biotechnologies Ltd New | 16.50 | +156.00% |
| LGVN | Longeveron Inc - Class A | 16.51 | +156.16% |
| ACOG | Alpha Cognition Inc | 16.80 | +160.66% |
| AXSM | Axsome Therapeutics Inc | 17.09 | +165.16% |
| PLUR | Pluri Inc | 17.50 | +171.52% |
| CANF | Can-Fite Biopharma Ltd | 17.56 | +172.45% |
| BEAM | Beam Therapeutics Inc | 17.79 | +176.02% |
| PRQR | ProQR Therapeutics N.V | 17.90 | +177.72% |
| IMNN | Imunon Inc | 17.94 | +178.34% |
| IPHA | Innate Pharma | 18.77 | +191.22% |
| ASND | Ascendis Pharma A/S | 20.12 | +212.17% |
| NRXS | Neuraxis Inc | 20.19 | +213.25% |
| EQ | Equillium Inc | 20.22 | +213.72% |
| LCTX | Lineage Cell Therapeutics Inc | 20.58 | +219.31% |
| VIVS | VivoSim Labs Inc | 20.99 | +225.67% |
| NTRB | Nutriband Inc | 21.11 | +227.53% |
| SEPN | Septerna Inc | 21.25 | +229.70% |
| PRLD | Prelude Therapeutics Inc | 21.25 | +229.70% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 21.98 | +241.03% |
| ZYME | Zymeworks BC Inc | 22.33 | +246.46% |
| CTMX | CytomX Therapeutics Inc | 22.42 | +247.85% |
| APM | Aptorum Group Limited Class A Ordinary Shares | 23.35 | +262.28% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | +268.49% |
| KALA | Kala Bio Inc | 23.75 | +268.49% |
| IRD | Ocuphire Pharma Inc | 23.98 | +272.06% |
| IGC | IGC Pharma Inc | 24.19 | +275.32% |
| VIR | Vir Biotechnology Inc | 24.75 | +284.00% |
| BRTX | BioRestorative Therapies Inc | 24.97 | +287.42% |
| NBP | NovaBridge Biosciences. | 25.39 | +293.93% |
| KRYS | Krystal Biotech Inc | 25.84 | +300.92% |
| CGEM | Cullinan Oncology Inc | 25.86 | +301.23% |
| ABCL | AbCellera Biologics Inc | 25.99 | +303.24% |
| RNXT | RenovoRx Inc | 26.04 | +304.02% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 26.45 | +310.38% |
| DARE | Dare Bioscience Inc | 26.79 | +315.66% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | +317.36% |
| ABVC | ABVC BioPharma Inc | 27.42 | +325.43% |
| ABEO | Abeona Therapeutics Inc | 27.67 | +329.31% |
| BBIO | BridgeBio Pharma Inc | 27.92 | +333.19% |
| NTLA | Intellia Therapeutics Inc | 28.12 | +336.29% |
| ARMP | Armata Pharmaceuticals Inc | 28.16 | +336.91% |
| INSM | Insmed Inc | 28.42 | +340.95% |
| RANI | Rani Therapeutics Holdings Inc Class A | 29.37 | +355.68% |
| VRDN | Viridian Therapeutics Inc | 29.68 | +360.49% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | +366.08% |
| ADAG | Adagene Inc | 31.61 | +390.44% |
| MESO | Mesoblast Ltd | 33.10 | +413.56% |
| SRZN | Surrozen Inc | 33.76 | +423.80% |
| RYTM | Rhythm Pharmaceuticals Inc | 34.39 | +433.57% |
| IMTX | Immatics N.V | 34.70 | +438.38% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | +440.09% |
| AGIO | Agios Pharmaceuticals Inc | 35.95 | +457.78% |
| CBIO | N/A | 36.36 | +464.14% |
| TOVX | Theriva Biologics Inc | 37.16 | +476.55% |
| CBUS | Cibus Global Ltd. Class A | 39.30 | +509.75% |
| XFOR | X4 Pharmaceuticals Inc | 40.81 | +533.18% |
| OCUL | Ocular Therapeutix Inc | 40.81 | +533.18% |
| NKTR | Nektar Therapeutics | 41.48 | +543.58% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | +553.97% |
| HYPD | Eyenovia Inc | 43.89 | +580.97% |
| EVMN | Evommune Inc | 44.84 | +595.71% |
| MCRB | Seres Therapeutics Inc | 45.04 | +598.81% |
| BYSI | BeyondSpring Inc | 45.99 | +613.55% |
| GLUE | Monte Rosa Therapeutics Inc | 46.04 | +614.32% |
| TRDA | Entrada Therapeutics Inc | 47.22 | +632.63% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | +644.89% |
| KRRO | Korro Bio Inc | 48.91 | +658.85% |
| SPRB | Spruce Biosciences Inc | 49.19 | +663.20% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | +688.64% |
| PPBT | Purple Biotech Ltd | 51.90 | +705.21% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | +714.55% |
| ALLR | Allarity Therapeutics Inc | 53.04 | +722.93% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | +729.15% |
| FATE | Fate Therapeutics Inc | 55.18 | +756.13% |
| CAMP | CAMP4 Therapeutics Corp | 55.57 | +762.19% |
| VYNE | VYNE Therapeutics Inc | 55.68 | +763.89% |
| PGEN | Precigen Inc | 57.77 | +796.32% |
| IBRX | ImmunityBio Inc | 57.87 | +797.87% |
| STOK | Stoke Therapeutics Inc | 58.07 | +800.97% |
| COCP | Cocrystal Pharma Inc | 58.22 | +803.30% |
| ONCY | Oncolytics Biotech Inc | 58.60 | +809.20% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | +828.44% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | +852.33% |
| NBTX | Nanobiotix | 62.26 | +865.98% |
| OVID | Ovid Therapeutics Inc | 64.47 | +900.27% |
| ACIU | AC Immune SA | 65.70 | +919.36% |
| EPIX | Essa Pharma Inc | 65.79 | +920.72% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | +934.56% |
| NRIX | Nurix Therapeutics Inc | 67.32 | +944.49% |
| JANX | Janux Therapeutics Inc | 71.18 | +1004.38% |
| ADXN | Addex Therapeutics Ltd | 71.50 | +1009.34% |
| APRE | Aprea Therapeutics Inc | 73.15 | +1034.95% |
| IVA | Inventiva | 73.66 | +1042.86% |
| LEXX | Lexaria Bioscience Corp | 75.14 | +1065.82% |
| SILO | SILO Pharma Inc | 76.31 | +1083.97% |
| OMER | Omeros Corporation | 76.82 | +1091.89% |
| MAZE | Maze Therapeutics Inc | 81.33 | +1161.86% |
| NRXP | NRX Pharmaceuticals Inc | 83.25 | +1191.65% |
| IMA | Ikena Oncology Inc | 83.32 | +1192.74% |
| TNGX | Tango Therapeutics Inc | 86.42 | +1240.83% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | +1242.85% |
| MIST | Milestone Pharmaceuticals Inc | 88.63 | +1275.12% |
| OGEN | Oragenics Inc | 89.28 | +1285.21% |
| ACRS | Aclaris Therapeutics Inc | 89.47 | +1288.16% |
| HUMA | Humacyte Inc | 90.61 | +1305.84% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | +1325.24% |
| CVM | Cel-Sci Corp | 92.88 | +1341.06% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | +1364.18% |
| RAPP | Rapport Therapeutics Inc | 95.49 | +1381.56% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | +1407.47% |
| HIND | ReShape Lifesciences Inc | 104.32 | +1518.56% |
| MREO | Mereo Biopharma Group Plc | 104.68 | +1524.14% |
| CYTK | Cytokinetics Inc | 105.12 | +1530.97% |
| OCGN | Ocugen Inc | 108.42 | +1582.17% |
| RLYB | Rallybio Corp | 109.04 | +1591.79% |
| AIM | AIM ImmunoTech Inc. | 112.05 | +1638.49% |
| MNOV | Medicinova Inc | 113.02 | +1653.54% |
| PTGX | Protagonist Therapeutics Inc | 113.99 | +1668.59% |
| SKYE | Skye Bioscience Inc | 117.90 | +1729.26% |
| UPB | Upstream Bio Inc | 119.09 | +1747.72% |
| GRDX | Entero Therapeutics Inc | 119.29 | +1750.82% |
| ZBIO | Zenas Biopharma Inc | 119.50 | +1754.08% |
| CAPR | Capricor Therapeutics Inc | 124.43 | +1830.57% |
| RNAC | Cartesian Therapeutics Inc | 142.69 | +2113.88% |
| OPT | Opthea Ltd | 151.40 | +2248.96% |
| EYPT | EyePoint Pharmaceuticals Inc | 152.51 | +2266.24% |
| DBVT | DBV Technologies | 153.33 | +2278.96% |
| PRME | Prime Medicine Inc | 156.26 | +2324.42% |
| MOLN | Molecular Partners AG | 156.56 | +2329.08% |
| QURE | uniQure N.V. | 157.78 | +2348.01% |
| NAMS | NewAmsterdam Pharma Company NV | 165.68 | +2470.58% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | +2535.74% |
| CRDF | Cardiff Oncology Inc | 175.81 | +2627.75% |
| KYMR | Kymera Therapeutics Inc | 182.36 | +2729.37% |
| GRCE | Acasti Pharma Inc | 197.75 | +2968.15% |
| LSTA | Lisata Therapeutics Inc | 200.88 | +3016.72% |
| GTBP | GT Biopharma Inc | 204.96 | +3080.02% |
| JUNS | Jupiter Neurosciences Inc | 212.82 | +3201.97% |
| SER | AgeX Therapeutics Inc | 224.96 | +3390.32% |
| ASBP | Aspire Biopharma Holdings Inc | 226.40 | +3412.67% |
| TSHA | Taysha Gene Therapies Inc | 238.09 | +3594.04% |
| AZTR | Azitra Inc | 239.97 | +3623.21% |
| GANX | Gain Therapeutics Inc | 255.50 | +3864.16% |
| CMPX | Compass Therapeutics Inc | 269.28 | +4077.96% |
| ATYR | Atyr Pharma Inc | 275.73 | +4178.04% |
| CYBN | Cybin Inc | 278.25 | +4217.14% |
| IBIO | iBio Inc | 279.86 | +4242.12% |
| YDES | YD Bio Ltd | 315.05 | +4788.10% |
| CDIO | Cardio Diagnostics Holdings Inc | 319.80 | +4861.80% |
| ATNM | Actinium Pharmaceuticals Inc | 320.69 | +4875.61% |
| CLRB | Cellectar Biosciences Inc | 348.47 | +5306.62% |
| VRNA | Verona Pharma Plc | 350.73 | +5341.69% |
| AUTL | Autolus Therapeutics plc | 372.63 | +5681.47% |
| ANIX | Anixa Biosciences Inc | 377.78 | +5761.37% |
| RLAY | Relay Therapeutics Inc | 398.28 | +6079.44% |
| TENX | Tenax Therapeutics Inc | 414.72 | +6334.51% |
| CADL | Candel Therapeutics Inc | 436.42 | +6671.19% |
| ALMS | Alumis Inc | 437.16 | +6682.67% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +7320.35% |
| CRNX | Crinetics Pharmaceuticals Inc | 491.45 | +7525.00% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +8259.34% |
| TVRD | Cara Therapeutics Inc | 559.61 | +8582.52% |
| IMRX | Immuneering Corp Class A | 563.62 | +8644.74% |
| ATAI | ATAI Life Sciences N.V. | 565.76 | +8677.94% |
| NGNE | Neoleukin Therapeutics Inc | 583.60 | +8954.74% |
| SLN | Silence Therapeutics Plc | 588.32 | +9027.97% |
| STTK | Shattuck Labs Inc | 608.39 | +9339.36% |
| LNAI | Lunai Bioworks Inc | 645.16 | +9909.86% |
| IMNM | Immunome Inc | 646.50 | +9930.65% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +9988.37% |
| CNTB | Connect Biopharma Holdings Ltd | 656.66 | +10088.29% |
| OTLK | Outlook Therapeutics Inc | 695.79 | +10695.40% |
| OCS | Oculis Holding AG | 705.51 | +10846.21% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +11186.46% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +11260.47% |
| INMB | INmune Bio Inc | 760.34 | +11696.91% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +12204.57% |
| TNYA | Tenaya Therapeutics Inc | 813.22 | +12517.36% |
| SNTI | Senti Biosciences Inc | 852.38 | +13124.94% |
| COGT | Cogent Biosciences Inc | 861.15 | +13261.01% |
| PROK | ProKidney Corp - Class A | 876.39 | +13497.46% |
| ABSI | Absci Corp | 900.52 | +13871.85% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +14688.26% |
| INBX | Inhibrx Biosciences Inc | 1029.47 | +15872.55% |
| CELZ | Creative Medical Technology Holdings Inc | 1195.26 | +18444.83% |
| CRSP | CRISPR Therapeutics AG | 1211.19 | +18691.99% |
| IBO | Impact BioMedical Inc | 1260.68 | +19459.84% |
| CGON | Cg Oncology Inc | 1269.73 | +19600.26% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +19687.76% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +20381.14% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +22537.62% |
| ENTX | Entera Bio Ltd | 1547.08 | +23903.43% |
| TCRT | Alaunos Therapeutics Inc | 1689.15 | +26107.69% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +26467.96% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +28945.60% |
| MBIO | Mustang Bio Inc | 2205.73 | +34122.59% |
| ABVX | Abivax | 2425.97 | +37539.68% |
| PULM | Pulmatrix Inc | 2459.21 | +38055.41% |
| BCDA | BioCardia Inc | 2520.59 | +39007.74% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +42879.43% |
| ROIV | Roivant Sciences Ltd | 3008.13 | +46572.08% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +47560.25% |
| CLDX | Celldex Therapeutics Inc | 3476.34 | +53836.50% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +53856.52% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +54410.57% |
| CMRX | Chimerix Inc | 3613.35 | +55962.25% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +56432.37% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +60274.89% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +62212.91% |
| DNTH | Dianthus Therapeutics Inc | 4088.10 | +63328.15% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +78810.26% |
| IFRX | InflaRx N.V. | 6161.81 | +95502.41% |
| GUTS | Fractyl Health Inc | 7575.74 | +117439.97% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +120676.78% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +131405.88% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +139567.29% |
| RVMD | Revolution Medicines Inc | 9035.10 | +140082.40% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +153117.59% |
| ALT | Altimmune Inc | 10694.01 | +165820.91% |
| LYEL | Lyell Immunopharma Inc | 11272.00 | +174788.60% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +200115.95% |
| GNLX | Genelux Corp | 16310.70 | +252965.61% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +278317.78% |
| DSGN | Design Therapeutics Inc | 29402.82 | +456093.94% |
| TRML | Tourmaline Bio Inc | 30893.12 | +479216.45% |
| TIL | Instil Bio Inc | 54248.82 | +841587.39% |
| ETNB | 89bio Inc | 111568.68 | +1730922.88% |
| EDSA | Edesa Biotech Inc | 130462.29 | +2024063.19% |
| SVRA | Savara Inc | 145272.62 | +2253850.09% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +7421936.74% |
| NKTX | Nkarta Inc | 1.00M | +15515212.45% |